Manuscripts
2020
- Colorectal Cancer Outcomes After Screening With the Multi-Target Stool DNA Assay: Protocol for a Large-Scale, Prospective Cohort Study (The Voyage Study). BMJ Open Gastroenterology [co-author]
- Estimating the Screening-Eligible Population Size, Aged 45 to 74, at Average Risk to Develop Colorectal Cancer in the United States. Cancer Prevention Research. [senior author]
2019
- CSF1R inhibitors exhibit anti-tumor activity in acute myeloid leukemia by blocking paracrine signals from support cells. Blood. [first author]
- FGF2-FGFR1 signaling regulates release of Leukemia-Protective exosomes from bone marrow stromal cells. Elife. [co-author]
2018
- Functional genomic landscape of acute myeloid leukaemia. Nature. [co-author]
- Automated decision tree to evaluate genetic abnormalities when determining prognostic risk in acute myeloid leukemia. Haematologica. [senior author]
- Targeting of colony-stimulating factor 1 receptor (CSF1R) in the CLL microenvironment yields antineoplastic activity in primary patient samples. Oncotarget. [first author]
2017
- Recurrent cyclin D2 mutations in myeloid neoplasms. Leukemia. [co-author]
- Identification of Interleukin-1 by Functional Screening as a Key Mediator of Cellular Expansion and Disease Progression in Acute Myeloid Leukemia. Cell Reports. [co-author]
